You Position: Home > Journal issue
Acta Pharmaceutica Sinica
2023:
2022:
2021:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2020:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2019:
- Issue 1 |
- Issue 2 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2018:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2017:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2016:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2015:
2008:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2007:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2006:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2005:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2004:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2003:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2002:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2001:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2000:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
1999:
1998:
Acta Pharmaceutica Sinica
1
Research progress in VEGFR-2 inhibitors
Acta Pharmaceutica Sinica, Volume 52, Issue 4,2017, Pages 531-540, doi:10.16438/j.0513-4870.2016-1103
2
GC-MS separation and determination of 20 amino acids in biological samples based on ethyl chloroformate second derivation
Acta Pharmaceutica Sinica, Volume 52, Issue 4,2017, Pages 615-619, doi:10.16438/j.0513-4870.2016-1028
3
Evaluation of plasma stability and pharmacokinetics of parthenolide in rats with LC-MS/MS analysis
Acta Pharmaceutica Sinica, Volume 52, Issue 4,2017, Pages 609-614, doi:10.16438/j.0513-4870.2016-1006
4
@@
Acta Pharmaceutica Sinica, Volume 52, Issue 4,2017, Pages 653-657, doi:10.16438/j.0513-4870.2015-0243
5
Molecular mechanism of Xuebijing injection in treatment of sepsis according to "drug-target-pathway" network
Acta Pharmaceutica Sinica, Volume 52, Issue 4,2017, Pages 556-562, doi:10.16438/j.0513-4870.2016-1048